Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial
- 1 February 1996
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 39 (3) , 213-215
- https://doi.org/10.1016/0006-3223(95)00585-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Intravenous glycine and oral d-Cycloserine effects on CSF Amino acids, plasma hormones and behavior in healthy humans: Implications for schizophreniaSchizophrenia Research, 1995
- Amelioration of negative symptoms in schizophrenia by glycineAmerican Journal of Psychiatry, 1994
- Systematic approach to the development of plasma amino acid analysis by high-performance liquid chromatography with ultraviolet detection with precolumn derivatization using phenyl isothiocyanateJournal of Chromatography B: Biomedical Sciences and Applications, 1993
- Recent advances in the phencyclidine model of schizophreniaAmerican Journal of Psychiatry, 1991
- An Open Trial of Glycine as an Adjunct to Neuroleptics in Chronic Treatment-Refractory SchizophrenicsJournal of Clinical Psychopharmacology, 1990
- The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical FoundationsThe British Journal of Psychiatry, 1989
- Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in SchizophreniaClinical Neuropharmacology, 1989
- Glycine Therapy of SchizophreniaBiological Psychiatry, 1988
- The Positive and Negative Syndrome Scale (PANSS) for SchizophreniaSchizophrenia Bulletin, 1987